Transplant Diagnostics Market to Reach US$ 17.2 Bn by 2035, Driven by Rising Organ Transplant Procedures and Advances in Molecular Diagnostics

The global transplant diagnostics market is witnessing steady expansion as healthcare systems increasingly rely on advanced diagnostic technologies to improve donor-recipient matching, assess organ compatibility, and monitor transplant outcomes. The market was valued at US$ 7.8 Bn in 2024 and is anticipated to grow at a CAGR of 7.3% between 2025 and 2035, reaching more than US$ 17.2 Bn by 2035.

Transplant diagnostics encompasses medical testing technologies used to evaluate compatibility between donors and recipients before transplantation and monitor patients after transplantation. These diagnostics help identify immunological incompatibility, infectious risks, and potential rejection.

Human leukocyte antigen (HLA) typing remains an important diagnostic approach for evaluating immune compatibility. In addition, molecular profiling, genetic testing, biomarker analysis, and circulating cell-free DNA (cfDNA) testing are expanding the capabilities of transplant diagnostics. Non-invasive diagnostics are gaining attention because they can provide information about transplant health while potentially reducing the need for invasive procedures.

Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20225

Key Drivers of Market Growth

One of the primary factors supporting transplant diagnostics market growth is the rising volume of organ transplantation procedures. Increasing prevalence of chronic conditions, population aging, kidney failure, liver disease, cardiovascular disorders, and other conditions requiring transplantation is generating demand for accurate compatibility and monitoring technologies.

Data from the Organ Procurement and Transplantation Network (OPTN) cited in the market information indicates that 48,149 organ transplants were reported in the U.S. in 2024, representing a 3.3% increase compared with 2023 and a 23.3% increase over five years.

Growing awareness and acceptance of organ donation are also expanding the potential donor pool. Government agencies, healthcare institutions, and nonprofit organizations are conducting awareness initiatives that emphasize the life-saving potential of transplantation. As the number of potential donors increases, hospitals and transplant centers require sophisticated diagnostics for donor-recipient matching, organ assessment, and post-transplant monitoring.

Technological innovation is another major growth factor. Genetic screening, molecular assays, biomarker identification, and immunological profiling are improving diagnostic sensitivity and specificity, supporting more individualized approaches to transplant care.

Emerging Trends

Next-generation sequencing and molecular profiling are becoming increasingly important in transplant diagnostics. These technologies can provide detailed genetic information that supports donor-recipient compatibility assessment and personalized treatment strategies.

AI and machine learning are also being incorporated into diagnostic workflows. These technologies can assist in processing large volumes of clinical and molecular data, potentially improving workflow efficiency and supporting interpretation.

The increasing use of non-invasive biomarkers, including donor-derived cfDNA, represents another important trend. Such technologies are being explored for monitoring transplant health and identifying potential rejection at an earlier stage.

The market is also seeing increased collaboration between diagnostic companies, healthcare institutions, research organizations, and biotechnology companies. These partnerships are helping accelerate research and product development while supporting expansion into emerging markets.

New Opportunities and Challenges

The growing adoption of personalized medicine presents significant opportunities for transplant diagnostics providers. Diagnostic platforms capable of combining genetic, molecular, immunological, and clinical information could support more individualized transplant management.

Emerging economies also offer opportunities as transplant infrastructure and healthcare access expand. Increasing investments in hospitals, laboratories, research centers, and organ-transplant programs could create additional demand for diagnostic instruments, kits, reagents, software, and services.

However, the market faces challenges including high costs associated with sophisticated diagnostic technologies, complex regulatory requirements, availability of specialized expertise, and differences in healthcare infrastructure across regions. Data management and integration can also become increasingly complex as diagnostic systems generate larger volumes of genomic and clinical information.

Regional Insight

North America held the leading share of the global transplant diagnostics market in 2024. The region benefits from advanced healthcare infrastructure, substantial research and development investment, established transplant networks, and the presence of major diagnostic technology companies.

The U.S. represents a major contributor to regional growth because of its sophisticated healthcare system, high transplantation activity, research capabilities, and adoption of advanced molecular diagnostic technologies. Increasing demand for personalized medicine and stringent regulatory frameworks are also encouraging the development and adoption of innovative diagnostic solutions.

Europe is supported by established healthcare systems, research capabilities, and transplantation programs, while Asia Pacific represents an important growth opportunity as healthcare infrastructure improves and awareness surrounding organ donation and transplantation increases. Latin America and the Middle East & Africa are also expected to witness opportunities as diagnostic capacity and transplant services expand.

Buy this Premium Research Report to access comprehensive analysis - https://www.transparencymarketresearch.com/checkout.php?rep_id=20225<ype=S

Competitive Landscape

The competitive landscape is characterized by product innovation, strategic collaborations, research initiatives, and expansion into developing markets. Companies are focusing on molecular testing, genetic analysis, biomarker identification, automated sample processing, and post-transplant monitoring technologies.

Prominent companies operating in the global transplant diagnostics market include Abbott, Bio-Rad Laboratories, Inc., QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, Inc., Siemens Healthineers, Agilent Technologies, Inc., Takara Bio Inc., Hologic, Inc., Werfen, S.A., and DiaSorin S.p.A.

Recent developments illustrate the industry's focus on non-invasive and personalized diagnostics. In October 2024, QIAGEN announced updates to its EZ2 Connect platform and related circulating cell-free DNA solutions for applications including organ transplantation. In July 2024, Thermo Fisher Scientific introduced a pre-transplant risk assessment assay designed to quantify the risk of early acute rejection in kidney transplant recipients.

Among market segments, kits and reagents represent a major product category because of their widespread use in genetic and immunological testing. The molecular assay segment also accounts for a significant share due to the sensitivity and specificity offered by molecular technologies such as PCR and NGS.

Future Outlook

The transplant diagnostics market is expected to maintain its growth trajectory through 2035 as transplantation volumes increase and diagnostic technologies become more precise. Greater adoption of molecular assays, NGS, genetic testing, biomarkers, cfDNA analysis, and AI-enabled workflows is expected to support the evolution of transplant medicine.

The market is projected to grow from US$ 7.8 Bn in 2024 to more than US$ 17.2 Bn by 2035, representing a CAGR of 7.3% during 2025–2035. Future developments are likely to focus on earlier identification of transplant complications, improved donor-recipient matching, automation, personalized immunosuppression strategies, and wider access to advanced diagnostic technologies.

Important FAQs with Answers

1. How big was the global transplant diagnostics market in 2024?

The global transplant diagnostics market was valued at US$ 7.8 Bn in 2024.

2. How big will the transplant diagnostics market be in 2035?

The market is projected to cross US$ 17.2 Bn by the end of 2035.

3. What is driving the transplant diagnostics market?

Key growth factors include the rising number of organ transplantation procedures, increasing organ donation awareness, technological advancements in molecular diagnostics, genetic testing, biomarker analysis, and growing adoption of personalized medicine.

4. What will be the CAGR of the transplant diagnostics market during 2025–2035?

The market is projected to expand at a CAGR of 7.3% from 2025 to 2035.

5. Which region dominated the transplant diagnostics market in 2024?

North America held the leading market share in 2024, supported by advanced healthcare infrastructure, research investment, transplantation networks, and diagnostic technology adoption.

6. Who are the prominent players in the transplant diagnostics market?

Major companies include Abbott, Bio-Rad Laboratories, QIAGEN, Bruker, Roche, Thermo Fisher Scientific, Becton, Dickinson and Company, QuidelOrtho, bioMérieux, Illumina, Siemens Healthineers, Agilent Technologies, Takara Bio, Hologic, Werfen, and DiaSorin.

Explore Latest Research Reports by Transparency Market Research-

Dengue Testing Market

Liver Cancer Diagnostics Market

PCR & Real-time PCR Molecular Diagnostics Market

SNP Genotyping and Analysis Market

Cell Free RNA Diagnostics Market

Gastric Cancer Diagnostics Market

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Media Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com